Gene Query: LGALS9

Dataset Description Geneva Score
Transcriptome of U251 cells overexpression complement component 7 86.91
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 80.37
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 80.37
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 74.02
Statins modulate endothelial transcriptional profile by inhibiting EZH2 72.89
Expression data from miR340 overexpressing human A549 cells 69.47
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 58.12
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 58.12
ZIKV infection of monocytes activates inflammasome pathways 56.44
Region-specific Innate Antiviral Responses of the Human Epididymis 54.81
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 54.78
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 54.78
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 52.48
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 49.59
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 46.71
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 44.82
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 43.67
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 42.75
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 42.75
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 42.29
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 41.88
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 40.47
H1609088 Human RNA-Sequencing 40.32
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 39.47
Transcriptional changes in lymphoma cells induced by LSD1 depletion 39.47
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 35.62
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 35.56
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 35.0
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 33.47
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 32.55
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 32.33
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 32.27
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 32.09
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 31.94
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 31.74
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 31.74
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 31.3
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 31.3
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 31.2
RNA-seq analysis of AML cells in response to ASLAN003 29.23
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 29.23
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 29.02
Be1 and Be2 B cells are transcriptionally distinct 27.9
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 26.86
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 26.51
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 26.42
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 25.59
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 25.56
SRSF2 mutations impair hematopoiesis and alter exon recognition 25.36
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 25.34
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 24.94
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 24.63
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 24.63
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 24.6
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 23.96
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 23.72
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 23.72
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 23.66
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 23.66
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 23.1
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 23.06
HNF1 regulates critical functions of the human epididymis epithelium. 23.06
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 22.86
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 22.86
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 22.6
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 22.11
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 22.04
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 21.93
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 21.82
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 21.69
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 21.55
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 20.87
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 20.87
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 20.71
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 20.58
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 19.59
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 19.57
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 19.43
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 19.14
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 19.03
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 19.01
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 18.93
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 18.79
Global analysis of alternative splicing regulated by RBM10 18.78
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 18.76
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 18.73
Molecular Mechanisms of Endothelial Hyperpermeability 18.68
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 18.67
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 18.61
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 18.6
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 18.6
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 18.3
The landscape of alternative splicing in aggressive prostate cancers 18.22
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 17.88
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 17.88
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 17.79
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 17.56
Patient-derived luminal breast cancer xenografts with progestins 17.43
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 17.43
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 17.36
Transcriptome analysis of virus infected tissues 16.94
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 16.85
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 16.55
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 16.23
Impact of dieldrin on transcription in Jurkat T cells 16.06
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 15.85
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 15.83
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 15.48
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 15.42
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 15.35
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 15.35
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 15.08
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 14.94
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.76
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.76
Transcriptome wide analysis of classically and alternatively activated macrophages 14.73
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 14.53
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 14.44
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 14.42
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 14.36
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 14.35
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 14.33
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 14.23
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 14.16
RNA seq analysis of human Fetal and adult derived Enterospheres 14.12
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 14.09
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 14.08
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 14.01
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 13.99
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 13.52
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 13.2
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 13.05
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 13.05
Transcriptional profiles of normal human mature B cells 13.03
Unique features and clinical importance of acute alloreactive immune responses 12.65
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 12.57
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 12.56
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 12.56
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 12.51
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 12.46
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 12.4
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 12.35
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 12.3
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 12.24
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 12.24
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 12.24
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 12.05
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.9
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 11.81
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 11.75
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 11.67
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 11.66
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 11.66
MYCi975 regulates MYC target genes 11.56
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 11.51
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 11.51
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 11.17
Human T-cell lymphoblastic lymphoma samples and control thymuses 11.17
Proliferation-correlated expression 11.08
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.01
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 10.87
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 10.77
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 10.72
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 10.72
CD74 role in transcription regulation [RNA-seq] 10.62
CD74 role in transcription regulation 10.62
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 10.62
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 10.55
Transcriptome of EBV-infected gastric cancer cell lines 10.55
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 10.49
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 10.49
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 10.42
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 10.34
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.31
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.31
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 10.29
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 10.28
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 10.28
Efficient derivation of microglia-like cells from human pluripotent stem cells 10.19
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 10.06
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 10.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 9.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 9.91
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 9.87
Hijacking of stress response machinery by oncogenes in acute leukaemia 9.87
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 9.81
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.78
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 9.73
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 9.7
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 9.7
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.61
Pharmacologic inhibition of STAT5 in AML 9.59
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.58
Intron retention induced by microsatellite expansions as a disease biomarker. 9.56
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 9.45
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 9.45
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 9.44
Transcriptome of diurnal human blood neutrophils 9.43
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 9.42
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 9.3
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 9.27
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 9.23
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 9.15
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.1
Regulating Interleukin-2 activity with engineered receptor signaling clamps 9.08
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 8.96
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 8.96
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 8.95
RNA-seq of CD33 KO and control HSPCs 8.88
RNA-seq of stable and unstable section of human atherosclerotic plaques 8.84
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 8.83
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 8.82
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 8.82
BACH2 in human plasma cell fate decision 8.78
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 8.77
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 8.75
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.72
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 8.66
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 8.62
naive T cell heterogeneity after neonatal thymectomy 8.61
SOX11 knockdown in B-ALL cell lines 8.6
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 8.57
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 8.55
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 8.55
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.49
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 8.42
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 8.42
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.37
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 8.33
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 8.33
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 8.26
Global gene expression profile of dasatinib-resistant RCH-ACV cells 8.23
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 8.1
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 8.09
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.04
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.04
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 8.0
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 8.0
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 7.98
Effect of Influenza virus infection on lncRNA expression in A549 cells 7.94
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 7.91
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 7.77
Nonpregnant and term pregnant human myometrial tissues 7.77
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 7.74
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.72
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 7.71
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 7.71
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.66
Single cell transcriptome of peritoneal cells 7.46
The comparison of high-throughput single-cell RNA-seq methods 7.39
Microglia innatly develop within cerebral organoids 7.36
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 7.27
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 7.26
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 7.23
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 7.22
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 7.22
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.21
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 7.16
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 7.16
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 7.02
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 6.98
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 6.98
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 6.93
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.93
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.86
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.85
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 6.77
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 6.69
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 6.69
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 6.62
Dynamic 3D chromosomal landscapes in acute leukemia 6.58
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 6.58
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.57
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 6.51
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 6.49
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 6.47
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 6.44
Morphological and molecular characterization of human dermal lymphatic collectors 6.38
Polarized B -cell functions 6.33
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 6.32
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 6.32
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.27
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.27
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 6.26
Reprogrammed myeloid cell transcriptomes in NSCLC 6.24
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.18
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.18
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.17
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 6.17
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.16
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 6.14
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 6.06
The role of the Calcium-Sensing receptor in colorectal cancer 5.97
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.96
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 5.88
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 5.84
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 5.69
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.68
Landscape and variation of RNA secondary structure across the human transcriptome 5.64
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.59
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.54
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 5.46
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 5.46
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 5.38
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 5.35
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.32
RNA Seq of HMVEC under hypoxia 5.32
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.32
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 5.31
RNA-sequencing of human tendon after injury 5.29
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 5.19
Fibroblasts in cholesteatoma activate osteoclasts. 5.18
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 5.16
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.16
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.14
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 5.1
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.04
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.04
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.03
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.03
Functional significance of the HIV-1 Tat signature amino acid residues 5.02
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.0
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 4.92
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.88
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 4.67
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.53
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.51
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 4.49
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.47
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.37
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.37
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 4.26
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 4.26
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.23
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 4.12
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 4.1
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 4.1
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.07
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.02
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.98
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.97
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.88
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.88
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.85
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.85
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.82
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.8
A practical evaluation of alignment algorithms for RNA variant calling analysis 3.79
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 3.73
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.66
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.64
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 3.61
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 3.57
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.55
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 3.48
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.47
TAF1 is critical for AE driven leukemogenesis 3.47
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 3.36
Human neutrophil genome during PMA- and E. coli encounter-induced activation 3.36
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 3.35
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.25
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 3.13
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 3.12
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.06
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.05
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.05
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 2.99
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.96
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.96
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.94
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 2.93
Total RNA-Seq data from leukemic patients with complex structural variants 2.92
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 2.91
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.9
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 2.87
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.8
LncRNA expression profiling of ischemic stroke patients 2.79
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.71
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.71
The Glioma-Infiltrating T Cell Receptor Repertoire 2.69
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.69
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.68
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.67
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.67
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.66
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.63
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.63
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.61
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.59
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 2.57
mRNA differential expression analysis in a human ex vivo model of chronic wounds 2.39
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.38
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.38
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.38
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.37
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.37
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.35
A single cell reference map for human blood and tissue T cell activation 2.35
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.33
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.32
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.32
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.3
Primary Human B-cell Temporal Response to CD40L Stimulation 2.29
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 2.27
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.26
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.26
MARCKS and lnc-MARCKS act as inflammation regulators 2.22
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.17
MRTF activates TEAD-YAP target gene expression 2.13
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.12
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.03
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.02
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 2.0
RNA sequencing of human pancreatic cancer cell lines 1.99
RNAseq of T-ALL upon long non coding rna purturbation 1.95
Transcriptome analysis of peripheral blood monocytes 1.94
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.93
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.88
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.87
Tpl-2 small molecule project 1.82
Tpl-2 and MEK small molecule inhibitors 1.82
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.82
RNA-seq in endometrial stromal tumors 1.8
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.77
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.73
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.68
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.68
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.66
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.66
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.58
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.49
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.48
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.48
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.45
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.44
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.44
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.41
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.4
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.39
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.38
An optimization system for isolating and sequencing of single human colon cancer cells 1.36
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.35
Expression patterns in chronic thromboembolic pulmonary hypertension 1.32
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.32
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.32
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.31
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.3
Identification of global regulators of T-helper cell lineage specification 1.3
Gene expression analysis of human liver progenitor-like cells in culture 1.29
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.26
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.24
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.24
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.22
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.17
MHC Transcriptomic landscape at haplotype-specific resolution 1.1
Identification of long noncoding RNAs in T-ALL cell lines 1.05
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.04
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.04
The cytokine environment influence on human skin-derived T cells 1.0
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.94
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.88
Gene expression analysis of human adenomas. 0.84
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.81
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.8
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.75
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.64
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.63
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.62
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.62
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.6
RNAseq analysis of ruxolitinib treated breast cancers 0.6
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.52
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.52
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.51
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.44
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.44
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.39
Hepatosplenic T cell lymphoma 0.39
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.36
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.36
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.31
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.31
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.24
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.21
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.15
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.13
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.13
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.09
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.09
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.05
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.05
Gene expression profile of CRC-derived HILEC 0.05
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.03
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.03
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.02
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation